Literature DB >> 21831464

Creating permissive microenvironments for stem cell transplantation into the central nervous system.

Howard Kim1, Michael J Cooke, Molly S Shoichet.   

Abstract

Traumatic injury to the central nervous system (CNS) is highly debilitating, with the clinical need for regenerative therapies apparent. Neural stem/progenitor cells (NSPCs) are promising because they can repopulate lost or damaged cells and tissues. However, the adult CNS does not provide an optimal milieu for exogenous NSPCs to survive, engraft, differentiate, and integrate with host tissues. This review provides an overview of tissue engineering strategies to improve stem cell therapies by providing a defined microenvironment during transplantation. The use of biomaterials for physical support, growth factor delivery, and cellular co-transplantation are discussed. Providing the proper environment for stem cell survival and host tissue integration is crucial in realizing the full potential of these cells in CNS repair strategies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831464     DOI: 10.1016/j.tibtech.2011.07.002

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  33 in total

1.  Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia.

Authors:  Yao Yao; Rui Zhou; Rui Bai; Jing Wang; Mengjiao Tu; Jingjing Shi; Xiao He; Jinyun Zhou; Liu Feng; Yuanxue Gao; Fahuan Song; Feng Lan; Xingguo Liu; Mei Tian; Hong Zhang
Journal:  Front Med       Date:  2020-12-01       Impact factor: 4.592

Review 2.  Biomaterials for spinal cord repair.

Authors:  Agnes E Haggerty; Martin Oudega
Journal:  Neurosci Bull       Date:  2013-07-18       Impact factor: 5.203

3.  Carbon nanotube composites as multifunctional substrates for in situ actuation of differentiation of human neural stem cells.

Authors:  John Landers; Jeffrey T Turner; Greg Heden; Aaron L Carlson; Neal K Bennett; Prabhas V Moghe; Alexander V Neimark
Journal:  Adv Healthc Mater       Date:  2014-04-22       Impact factor: 9.933

Review 4.  Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Authors:  Yao-Hui Tang; Yuan-Yuan Ma; Zhi-Jun Zhang; Yong-Ting Wang; Guo-Yuan Yang
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

Review 5.  Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.

Authors:  James P Harris; Justin C Burrell; Laura A Struzyna; H Isaac Chen; Mijail D Serruya; John A Wolf; John E Duda; D Kacy Cullen
Journal:  NPJ Parkinsons Dis       Date:  2020-01-08

6.  RhoC involved in the migration of neural stem/progenitor cells.

Authors:  Can Zhang; Xuemei Ge; Kenghoe Lok; Lu Zhao; Ming Yin; Ze-Jian Wang
Journal:  Cell Mol Neurobiol       Date:  2014-01-11       Impact factor: 5.046

Review 7.  Recent advances in nanotherapeutic strategies for spinal cord injury repair.

Authors:  Young Hye Song; Nikunj K Agrawal; Jonathan M Griffin; Christine E Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2018-12-22       Impact factor: 15.470

Review 8.  Engineering therapies in the CNS: what works and what can be translated.

Authors:  Andrew J Shoffstall; Dawn M Taylor; Erin B Lavik
Journal:  Neurosci Lett       Date:  2012-02-04       Impact factor: 3.046

Review 9.  Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.

Authors:  Deepaneeta Sarmah; Harpreet Kaur; Jackson Saraf; Kanta Pravalika; Avirag Goswami; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Transl Stroke Res       Date:  2017-10-26       Impact factor: 6.829

10.  MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Expression of Synaptic and Autophagic Proteins.

Authors:  Ana L Morgado; Joana M Xavier; Pedro A Dionísio; Maria F C Ribeiro; Raquel B Dias; Ana M Sebastião; Susana Solá; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2014-06-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.